All HHS Contracts — June 18, 2026

The $120.25 million firm-fixed-price delivery order from BARDA places cost overrun risk on the nonprofit recipient for health R&D services, which typically have uncertain cost trajectories.

Fixed-price structure on R&D services (NAICS 541714) exposes Advanced Technology International to potential cost overruns, as R&D often involves unpredictable expenses.

Single contract represents 100% of the digest's total obligation, with no diversification across other HHS recipients or agencies.

The multi-year BARDA award through 2028 provides a stable, predictable revenue stream for Advanced Technology International, with $39.86 million already outlayed, indicating ongoing performance.

The single $120.25 million award to a nonprofit under full-and-open competition reflects routine, non-competitive HHS/BARDA procurement for health R&D services, with no set-aside or sole-source signal.

{"entity"=>"Advanced Technology International", "reason"=>"Nonprofit recipient of a $120.25 million fixed-price R&D contract; financial health and execution capability are key.", "trigger"=>"Any modifications, extensions, or additional task orders under this delivery order"}

{"entity"=>"HHS/BARDA", "reason"=>"Agency's continued spending on health R&D and potential follow-on contracts.", "trigger"=>"New BARDA contract announcements or budget allocations for health R&D"}